Curcumin Disrupts the Mammalian Target of Rapamycin-Raptor Complex

¹Department of Biochemistry and Molecular Biology and ²Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana; and ³Department of Medicine, University of California, San Diego, La Jolla, California

^* To whom correspondence should be addressed. E-mail: shuan1{at}lsuhsc.edu.

	Abstract

Curcumin (diferuloylmethane), a polyphenol natural product of the plant Curcuma longa, is undergoing early clinical trials as a novel anticancer agent. However, the anticancer mechanism of curcumin remains to be elucidated. Recently, we have shown that curcumin inhibits phosphorylation of p70 S6 kinase 1 (S6K1) and eukaryotic initiation factor 4E (eIF4E) binding protein 1 (4E-BP1), two downstream effector molecules of the mammalian target of rapamycin complex 1 (mTORC1) in numerous cancer cell lines. This study was designed to elucidate the underlying mechanism. We observed that curcumin inhibited mTORC1 signaling not by inhibition of the upstream kinases, such as insulin-like growth factor 1 receptor (IGF-IR) and phosphoinositide-dependent kinase 1 (PDK1). Further, we found that curcumin inhibited mTORC1 signaling independently of protein phosphatase 2A (PP2A) or AMP-activated protein kinase AMPK-tuberous sclerosis complex (TSC). This is evidenced by the findings that curcumin was able to inhibit phosphorylation of S6K1 and 4E-BP1 in the cells pretreated with PP2A inhibitor (okadaic acid) or AMPK inhibitor (compound C), or in the cells expressing dominant-negative (dn) PP2A, shRNA to PP2A-A subunit, or dn-AMPK. Curcumin did not alter the TSC1/2 interaction. Knockout of TSC2 did not affect curcumin inhibition of mTOR signaling. Finally, we identified that curcumin was able to dissociate raptor from mTOR, leading to inhibition of mTORC1 activity. Therefore, our data indicate that curcumin may represent a new class of mTOR inhibitor. [Cancer Res 2009;69(3):1000–8]

Key Words: Curcumin, mammalian target of rapamycin, raptor, rictor, Akt

This article has been cited by other articles:

				S. M. JOHNSON, P. GULHATI, I. ARRIETA, X. WANG, T. UCHIDA, T. GAO, and B. M. EVERS Curcumin Inhibits Proliferation of Colorectal Carcinoma by Modulating Akt/mTOR Signaling Anticancer Res, August 1, 2009; 29(8): 3185 - 3190. [Abstract] [Full Text] [PDF]

				D. A. Guertin and D. M. Sabatini The Pharmacology of mTOR Inhibition Sci. Signal., April 21, 2009; 2(67): pe24 - pe24. [Abstract] [Full Text] [PDF]